Traders are growing fearful that the takeover of Ansys (ANSS) by Synopsys (SNPS) will get bogged down by China’s antitrust regulators, Yiqin Shen and Neil Campling of Bloomberg report. The deal spread has widened to over $40 per share on growing uncertainty the deal will win approval from China amid the trade war, according to Bloomberg. The deal has received regulatory approval in the U.S., UK, Europe, with China the last significant holdout, it points out.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANSS:
- Market’s Tariff Tantrum Overshadows Positive Developments for IonQ (IONQ)
- Quantum Leap: Quantinuum to launch Helios device this year
- IonQ Stock Rises After Quantum Breakthrough in Medical Device Design
- IonQ, Ansys announce quantum computing application in medical devices
- AI Daily: Nvidia presents new AI chips, partnerships at GTC